Ipsen Pharmaceuticals

image of two race cars neck and neck
Biotech

Ipsen joins ADC race via $900M biobuck deal with Sutro

Ipsen is the newest entrant in the antibody-drug conjugate race, handing over around $90 million in near-term payments to Sutro Biopharma
James Waldron Apr 2, 2024 7:26am
apoptosis cell death cancer cell death

Cell death biotech folds in 'challenging funding environment'

Jul 11, 2023 4:00am
parachute sunset paragliding chutes

BMS CEO set to leave after 8-year run—Chutes & Ladders

Apr 28, 2023 9:30am
FDA

FDA agrees to give Ipsen's rare disease drug another look

Mar 17, 2023 7:12am
Abstract image of a human brain-stock image Khanchit KhirisutchalualGetty Images

Irlab's Ipsen-partnered Parkinson's drug flunks phase 2 trial

Jan 18, 2023 10:08am
relay race baton pass

BioCryst leaves ultra-rare disease efforts in hands of peers

Nov 1, 2022 10:00am